Author:
van Beek N.,Zillikens D.,Schmidt E.
Publisher
Springer Science and Business Media LLC
Reference112 articles.
1. Ahmed AR, Shetty S (2015) A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab. Autoimmun Rev 14:323–331
2. Amagai M, Ikeda S, Shimizu H et al (2009) A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 60:595–603
3. Amber KT, Lamberts A, Solimani F et al (2017) Determining the incidence of pneumocystis pneumonia in patients with autoimmune blistering diseases not receiving routine prophylaxis. Jama Dermatol 153:1137–1141
4. Anhalt G, Strober B, Connolly M, Korman N, Greenstein D, Fantasia J, Kalish R (2005) An open-label phase I clinical study to assess the safety of PI-0824 in patients with pemphigus vulgaris. J Invest Dermatol 125:Abs23
5. Anhalt GJ (2004) Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 9:29–33
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献